AuthorsThompson DK, Huffman KM, Kraus WE, Kraus VB,
JournalPLoS One
PubMed ID22347395
Interleukin-6 (IL-6) contributes to numerous inflammatory, metabolic, and physiologic pathways of disease. We evaluated four IL-6 immunoassays in order to identify a reliable assay for studies of metabolic and physical function. Serial plasma samples from intravenous glucose tolerance tests (IVGTTs), with expected rises in IL-6 concentrations, were used to test ... More
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
AuthorsPetta S, Amato MC, Di Marco V, Cammà C, Pizzolanti G, Barcellona MR, Cabibi D, Galluzzo A, Sinagra D, Giordano C, Craxì A,
JournalAliment Pharmacol Ther
PubMed ID22117531
Metabolic factors have been associated with liver damage in patients with non-alcoholic fatty liver disease (NAFLD). To test a new marker of adipose dysfunction, the visceral adiposity index (VAI), in NAFLD patients to assess whether or not it is associated with host factors, and to investigate a potential correlation with ... More